(Alliance News) - Stocks in London closed higher on Wednesday, led by gains in financials, despite a drop in BP as a much-awaited strategy update underwhelmed. Read More
(Alliance News) - Stock prices in London opened in the green, with major corporate news including the release of positive full-year results by Convatec. Read More
(Alliance News) - Hikma Pharmaceuticals PLC on Wednesday said it planned to increased spending on research and development to support further growth after reporting strong annual results. Read More
(Alliance News) - London stocks were set to open higher on Wednesday morning, with UK Prime Minister Keir Starmer flying to the US for talks with Donald Trump. Read More
(Alliance News) - Stocks closed lower on Tuesday, giving back Monday's gains, as weak Chinese trade data put hopes for a stimulus-based rally on hold. Read More
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading to date, and reiterates its full-year revenue expectations. Read More
(Alliance News) - Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form business. Denmark-based Xellia Pharmaceuticals ApS. Read More
(Alliance News) - Stocks in London were seen higher early on Tuesday, as investors prepare for manufacturing purchasing managers' index data from both the US and Canada following Labor Day. Read More
Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Reports that Bassam Kanaan, executive vice president of corporate development and M&A, sold 35,000 shares at 1,960 pence each for GBP686,000 on Thursday. He subsequently sold 10,000 shares at 2,025p each for GBP202,500. Proceeds for the disposals total GBP888,500. Both transactions took place on the London Stock Exchange. Read More
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday increased its interim dividend following double-digit growth across the business in the first half. Read More